PF PRISM CV FDA Approval NDA 021083

NDA 021083

PF PRISM CV

FDA Drug Application

Application #021083

Documents

Letter2003-04-18
Letter2003-01-23
Letter2004-06-14
Letter2005-07-08
Letter2005-10-14
Letter2006-06-06
Letter2007-01-16
Letter2007-02-12
Letter2007-01-25
Letter2007-05-09
Letter2007-10-22
Letter2008-03-07
Letter2009-11-10
Letter2010-12-07
Letter2010-07-08
Letter2010-12-07
Letter2011-07-13
Letter2011-06-09
Letter2013-03-08
Letter2013-09-17
Letter2015-05-29
Letter2015-03-10
Letter2015-11-09
Label2003-01-23
Label2003-01-23
Label2003-01-23
Label2003-10-10
Label2005-07-07
Label2005-07-07
Label2005-10-14
Label2006-06-06
Label2007-01-16
Label2008-01-18
Label2007-10-22
Label2008-03-07
Label2009-02-04
Label2009-10-01
Label2010-05-03
Label2010-05-03
Label2010-08-27
Label2012-12-14
Label2015-03-09
Label2015-11-12
Review1999-09-15
Review2009-09-14
Letter1999-09-15
Letter2003-01-23
Letter2003-01-23
Letter2003-01-23
Letter2003-01-23
Letter2003-10-09
Letter2004-07-21
Letter2005-03-14
Letter2005-07-08
Letter2005-10-14
Letter2006-06-06
Letter2008-01-18
Letter2008-03-10
Letter2009-11-10
Letter2010-04-28
Letter2010-04-28
Letter2010-02-01
Letter2010-11-08
Letter2012-12-11
Label2003-04-11
Label2003-01-23
Label2003-01-23
Label2003-03-26
Label2004-07-21
Label2005-03-14
Label2005-10-14
Label2006-06-06
Label2006-10-23
Label2007-01-16
Label2007-05-07
Label2008-03-07
Label2009-10-14
Label2010-12-01
Label2010-02-04
Label2010-12-01
Label2010-11-04
Label2013-03-08
Label2015-06-01
Label2017-04-12
Label2018-01-16
Medication Guide2018-01-16
Letter2018-01-17
Pediatric Medical Review1900-01-01
Pediatric Clinical Pharmacology Review1900-01-01
Pediatric Statistical Review1900-01-01
Pediatric Written Request1900-01-01
Letter2018-05-24
Label2018-05-25
Label2019-04-08
Medication Guide2019-04-08
Letter2019-04-08
Letter2019-06-19
Letter2019-07-16
Label2019-07-16
Medication Guide2019-07-16
Label2019-08-08
Letter2020-01-03
Label2020-01-06
Medication Guide2020-01-06
Letter2022-08-23
Letter2022-08-23
Label2022-08-23
Label2022-08-23
Medication Guide2022-08-23

Application Sponsors

NDA 021083PF PRISM CV

Marketing Status

Prescription001

Application Products

001SOLUTION;ORAL1MG/ML1RAPAMUNESIROLIMUS

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1999-09-15PRIORITY
LABELING; LabelingSUPPL2AP2000-05-03STANDARD
LABELING; LabelingSUPPL4AP2000-08-25STANDARD
LABELING; LabelingSUPPL5AP2003-01-23STANDARD
EFFICACY; EfficacySUPPL6AP2003-04-11STANDARD
LABELING; LabelingSUPPL7AP2003-01-23STANDARD
LABELING; LabelingSUPPL8AP2003-01-23STANDARD
LABELING; LabelingSUPPL9AP2003-01-23STANDARD
LABELING; LabelingSUPPL10AP2003-01-23STANDARD
LABELING; LabelingSUPPL12AP2003-01-31STANDARD
LABELING; LabelingSUPPL14AP2003-03-19STANDARD
LABELING; LabelingSUPPL15AP2003-10-02STANDARD
LABELING; LabelingSUPPL17AP2004-07-20STANDARD
EFFICACY; EfficacySUPPL19AP2005-03-11PRIORITY
LABELING; LabelingSUPPL20AP2005-06-30STANDARD
LABELING; LabelingSUPPL21AP2005-06-30STANDARD
LABELING; LabelingSUPPL22AP2005-10-07STANDARD
LABELING; LabelingSUPPL23AP2005-10-07STANDARD
EFFICACY; EfficacySUPPL24AP2006-06-02UNKNOWN
LABELING; LabelingSUPPL25AP2006-06-02STANDARD
LABELING; LabelingSUPPL26AP2007-01-09STANDARD
LABELING; LabelingSUPPL28AP2006-10-19STANDARD
EFFICACY; EfficacySUPPL29AP2007-01-30UNKNOWN
LABELING; LabelingSUPPL30AP2007-01-12STANDARD
LABELING; LabelingSUPPL31AP2007-05-02STANDARD
EFFICACY; EfficacySUPPL33AP2008-01-14STANDARD
LABELING; LabelingSUPPL34AP2007-10-17STANDARD
LABELING; LabelingSUPPL36AP2008-03-05STANDARD
LABELING; LabelingSUPPL37AP2008-03-05STANDARD
LABELING; LabelingSUPPL38AP2009-01-29STANDARD
LABELING; LabelingSUPPL40AP2009-09-24STANDARD
LABELING; LabelingSUPPL41AP2009-10-08901 REQUIRED
LABELING; LabelingSUPPL42AP2010-04-22UNKNOWN
LABELING; LabelingSUPPL43AP2010-04-22UNKNOWN
LABELING; LabelingSUPPL44AP2010-11-23UNKNOWN
LABELING; LabelingSUPPL45AP2010-01-25UNKNOWN
LABELING; LabelingSUPPL46AP2010-07-02UNKNOWN
LABELING; LabelingSUPPL47AP2010-11-23901 REQUIRED
LABELING; LabelingSUPPL48AP2010-11-08STANDARD
LABELING; LabelingSUPPL49AP2011-07-11UNKNOWN
REMS; REMSSUPPL50AP2011-06-06N/A
LABELING; LabelingSUPPL51AP2012-12-10STANDARD
LABELING; LabelingSUPPL53AP2013-03-07STANDARD
LABELING; LabelingSUPPL54AP2013-05-30STANDARD
EFFICACY; EfficacySUPPL55AP2015-05-28PRIORITY
LABELING; LabelingSUPPL56AP2015-03-06STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL57AP2015-07-31PRIORITY
LABELING; LabelingSUPPL58AP2015-11-05STANDARD
LABELING; LabelingSUPPL59AP2017-04-11STANDARD
LABELING; LabelingSUPPL61AP2018-05-23STANDARD
LABELING; LabelingSUPPL62AP2018-01-12STANDARD
LABELING; LabelingSUPPL64AP2019-07-15STANDARD
LABELING; LabelingSUPPL65AP2019-04-05STANDARD
LABELING; LabelingSUPPL66AP2019-06-18STANDARD
LABELING; LabelingSUPPL67AP2020-01-02STANDARD
LABELING; LabelingSUPPL69AP2022-08-22STANDARD
LABELING; LabelingSUPPL70AP2022-08-22STANDARD

Submissions Property Types

ORIG1Null25
SUPPL17Null9
SUPPL19Null26
SUPPL28Null9
SUPPL40Null7
SUPPL41Null6
SUPPL42Null6
SUPPL43Null6
SUPPL44Null6
SUPPL45Null6
SUPPL46Null6
SUPPL47Null6
SUPPL48Null6
SUPPL49Null6
SUPPL50Null6
SUPPL51Null6
SUPPL53Null15
SUPPL54Null6
SUPPL55Null6
SUPPL56Null7
SUPPL57Null0
SUPPL58Null6
SUPPL59Null6
SUPPL61Null15
SUPPL62Null6
SUPPL64Null15
SUPPL65Null6
SUPPL66Null7
SUPPL67Null7
SUPPL69Null7
SUPPL70Null31

TE Codes

001PrescriptionAA

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21083
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.